Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vagin
- 31 December 1994
- Vol. 12 (3) , 200-209
- https://doi.org/10.1016/0264-410x(94)90195-3
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Immunological memory to herpes simplex virus type 1 glycoproteins B and D in miceJournal of General Virology, 1990
- Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulationVaccine, 1990
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.The Journal of Experimental Medicine, 1986
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Suppression of Frequently Recurring Genital HerpesNew England Journal of Medicine, 1984
- DNA sequence of the Herpes simplex virus type 2 glycoprotein D geneGene, 1983
- Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral AcyclovirNew England Journal of Medicine, 1983
- Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2Archiv für die gesamte Virusforschung, 1979
- Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells.The Journal of Experimental Medicine, 1978